Entero Healthcare Solutions Gears Up for Q3 Reveal on 12th February; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

Entero Healthcare Solutions ‘s Q3 results FY26 are scheduled to be announced on 12th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Entero Healthcare Solutions Q3 Results 2026 Preview

• Entero Healthcare Solutions’ revenue is expected to be in the range of ₹1,359.00 crore, a 4.48% YoY increase. 
• Profit After Tax, or PAT, is projected to rise 7.72% YoY. 
• Net profit is ₹25.44 crore, a rise 7.72% YoY 
• EBITDA to rise 19.91%

Entero Healthcare Solutions Share Performance 

• Over the past six months, Entero Healthcare Solutions’ share price has fallen by 3.38% to ₹1,145.00.
• Moreover, over the past year, the stock has decreased by 14.27%.
• Despite this weak short-term performance, Entero Healthcare Solutions’ stock has delivered a financially sound 0.40% return over the past 5 years.
• As of 11th February 2026, the stock traded at ₹1,145.00 per share.

Key Factors to Watch for Entero Healthcare Solutions Q3 Results FY26

• Revenue & Sales Growth: Check how much the company’s total sales have grown, especially from pharmaceutical distribution and MedTech products.
  
• Profitability & Margins: Watch EBITDA and net profit margins to see if the company is controlling costs and improving profitability.
  
• Acquisition Impact: Performance and contribution and other acquisitions towards overall renue growth.

• Working Capital & Cash Flow: How well the company manages inventory, collections and whether cash flow is improving.
  

Final Thoughts

Entero Healthcare Solutions will announce its Q3 FY26 results on 12th February 2026. Analysts expect 4.48% revenue growth, a 7.72% rise  in PAT, and a 19.91% rise in EBITDA. Entero Healthcare Solutions focuses on revenue growth from order execution, margin improvement, the strength of order book, and management.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

GOCL Corporation Q3 Results FY26 Preview

Godrej Industries Q3 Results FY26 Preview

Godawari Power and Ispat Q3 Results FY26 Preview

Hikal Q3 Results FY26 Preview

Himatsingka Seide Q3 Results FY26 Preview

Igarashi Motors India FY26 Preview

IG Petrochemicals Ltd Q3 Results FY26 Preview

IOL Chemicals & Pharmaceuticals Q3 Results FY26 Preview